KRISTEN COFFMAN: Open Payments
NPI 1104312420 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 6 companies in 2025. Trend: 2023 $283 · 2024 $186 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| ABBVIE INC. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: ABILIFY MAINTENA, INGREZZA, VRAYLAR, INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII, COBENFY.
Industry payments across AR — which companies pay providers there.
